K
PharmaceuticalsSmallcap
Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare.
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 14.29 | 34.78 |
| PB Ratio | 1.06 | 5.49 |
| Dividend Yield | 2.63% | 0.61% |
Understand what these metrics mean.
For peer comparison & financials,